C1 inhibiting factor; C1-INH
C1 esterase inhibitor (C1-INH) is a protein found in the fluid part of your blood. It controls a protein called C1, which is part of the complement system.
The complement system is a group of nearly 60 proteins in blood plasma or on the surface of some cells. The complement proteins work with your immune system to protect the body from infections. They also help remove dead cells and foreign material. There are nine major complement proteins. They are labeled C1 through C9. Rarely, people may inherit deficiency of some complement proteins. These people are prone to certain infections or autoimmune disorders.
This article discusses the test that is done to measure the amount of C1-INH in your blood.
A blood sample is needed. This is most often taken through a vein. The procedure is called a venipuncture.
No special preparation is needed.
When the needle is inserted to draw blood, some people feel moderate pain. Others may feel only a prick or stinging sensation. Afterward, there may be some throbbing.
You may need this test if you have signs of hereditary or acquired angioedema. Both forms of angioedema are caused by low levels of C1-INH.
Complement factors may also be important in testing for autoimmune diseases, such as systemic lupus erythematosus.
Normal value ranges may vary slightly among different laboratories. Your health care provider will also measure the functional activity level of your C1 esterase inhibitor. Talk to your provider about the meaning of your specific test results.
Low levels of C1-INH may cause certain types of angioedema. Angioedema results in sudden swelling of the tissues of the face, upper throat and tongue. It may also cause difficulty breathing. Swelling in the intestine and abdominal pain may also occur. There are two types of angioedema that result from decreased levels of C1-INH. Hereditary angioedema affects children and young adults under age 20. Acquired angioedema is seen in adults older than age 40. Adults with acquired angioedema are much more likely to also have other conditions, such as such as cancer or autoimmune disease.
Risks associated with having blood drawn are slight, but may include:
Atkinson JP, Du Clos TW, Mold C, Kulkarni H, Hourcade D, Wu X. The human complement system: basic concepts and clinical relevance. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, eds. Clinical Immunology: Principles and Practice. 5th ed. Philadelphia, PA: Elsevier; 2019:chap 21.
Cicardi M, Aberer W, Banerji A, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69(5):602-616. PMID: 24673465 www.ncbi.nlm.nih.gov/pubmed/24673465/.
Leslie TA, Greaves MW. Hereditary angioedema. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson IH, eds. Treatment of Skin Disease: Comprehensive Therapeutic Strategies. 5th ed. Philadelphia, PA: Elsevier; 2018:chap 101.
Zanichelli A, Azin GM, Wu MA, et al. Diagnosis, course, and management of angioedema in patients with acquired C1-inhibitor deficiency. J Allergy Clin Immunol Pract. 2017;5(5):1307-1313. PMID: 28284781 www.ncbi.nlm.nih.gov/pubmed/28284781/.BACK TO TOP
Review Date: 1/31/2021
Reviewed By: Diane M. Horowitz, MD, Rheumatology and Internal Medicine, Northwell Health, Great Neck, NY. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Health Content Provider
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2022 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.